natural substance from Neem tree with medicinal and pesticidal properties
a novel topical treatment that inhibits DHT on androgen receptors
- Can I use clascoterone if I'm undergoing gender-affirming hormone therapy? No published clinical trial has tested clascoterone in people on gender-affirming hormone therapy, so its safety in that group is unknown. The FDA label reports low systemic exposure and no described effect on blood testosterone, but it also records HPA-axis suppression and raised potassium in a small minority of subjects.
a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor